 | Up a level |
Haber, Philipp K; Castet, Florian; Torres-Martin, Miguel; Andreu-Oller, Carmen; Puigvehí, Marc; Maeda, Miho; Radu, Pompilia; Dufour, Jean-Francois; Verslype, Chris; Czauderna, Carolin; Marquardt, Jens U; Galle, Peter R; Vogel, Arndt; Bathon, Melanie; Meyer, Tim; Labgaa, Ismail; Digklia, Antonia; Roberts, Lewis R; Mohamed Ali, Mohamed A; Mínguez, Beatriz; ... (2023). Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology, 164(1), 72-88.e18. Elsevier 10.1053/j.gastro.2022.09.005
Scheiner, Bernhard; Roessler, Daniel; Phen, Samuel; Lim, Mir; Pomej, Katharina; Pressiani, Tiziana; Cammarota, Antonella; Fründt, Thorben W.; von Felden, Johann; Schulze, Kornelius; Himmelsbach, Vera; Finkelmeier, Fabian; Deibel, Ansgar; Siebenhüner, Alexander R.; Shmanko, Kateryna; Radu, Pompilia; Schwacha-Eipper, Birgit; Ebert, Matthias P.; Teufel, Andreas; Djanani, Angela; ... (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP reports, 5(1), p. 100620. Elsevier 10.1016/j.jhepr.2022.100620
Radu, Pompilia; Ebadi, Maryam; Montano-Loza, Aldo J; Dufour, Jean François (2022). What Is the Role of Body Composition Assessment in HCC Management? Cancers, 14(21) MDPI AG 10.3390/cancers14215290
Radu, Iuliana-Pompilia; Dufour, Jean-François (2022). Sonography in surveillance for HCC in NAFLD patients. Hepatoma research, 8, p. 38. OAE Publishing 10.20517/2394-5079.2022.42
Lange, Naomi F.; Radu, Pompilia; Dufour, Jean-François (2021). Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention. Journal of hepatology, 75(5), pp. 1217-1227. Elsevier 10.1016/j.jhep.2021.07.025
Moser, Monika; Radu, Iuliana-Pompilia; Dufour, Jean-François (2021). Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib. JGH open, 5(8), pp. 864-870. Wiley 10.1002/jgh3.12533
von Hessen, Leona; Roumet, Marie; Maurer, Martin; Lange, Naomi; Reeves, Helen; Dufour, Jean-François; Radu, Pompilia (2021). High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma. Liver international, 41(4), pp. 828-836. Wiley 10.1111/liv.14755
Spahn, Stephan; Roessler, Daniel; Radu, Pompilia; Gabernet, Gisela; Gladstone, Beryl Primrose; Horger, Marius; Biskup, Saskia; Feldhahn, Magdalena; Nahnsen, Sven; Hilke, Franz J; Scheiner, Bernhard; Dufour, Jean-François; De Toni, Enrico N; Pinter, Matthias; Malek, Nisar P; Bitzer, Michael (2020). Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma. Cancers, 12(12) MDPI AG 10.3390/cancers12123830
Sparchez, Zeno; Mocan, Tudor; Radu, Pompilia; Nenu, Iuliana; Comsa, Mihai; Hajjar, Nadim Al; Mois, Emil; Bartos, Adrian; Kacso, Gabriel; Sparchez, Mihaela (2020). Microwave ablation in the treatment of liver tumors. A better tool or simply more power? Medical ultrasonography, 22(4), pp. 451-460. Medical Publishing House of the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 10.11152/mu-2556
Radu, Pompilia; Dufour, Jean-François (2020). Changing TACTICS in intermediate HCC: TACE plus sorafenib. Gut, 69(8), pp. 1374-1376. BMJ Publishing Group 10.1136/gutjnl-2020-320692
